Skip to content

COSMEDIC

Active
Private limited companyfounded 2007active for 18 yearsRopstocklei 10, 2530 Boechout, BelgiumKBO/BCE: BE 0893.282.995
Summary

COSMEDIC has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €250,609 and a net result of €52,554. Equity has been growing by about 4.5% per year since 2019. Its solvency ranks better than 79% of 13,749 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 07-11-2007 Normal situation
Activity
Wholesale of pharmaceutical and medical goods NACE 46460
Establishment unit
2.166.562.306 2530 Boechout, since 31-10-2007
Financial year end
30 June
Peppol
Reachable since 15-11-2025

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€70,770
Turnover
≈ €270,000
estimated
Profit
€52,554
Equity
€250,609
▲ 18.2%
Total assets
€331,807
▲ 12.1%
Score breakdownraises riskSector: Wholesale trade (NACE 46)lowers riskLiquidity: current ratio 5.23, cash €155,213Equity €250,609 (75.5% of total assets)Founded in 2007Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 85% of micro companies in wholesale trade (NACE 46)
Financial strength · tick: 2024
Strong
Solvency 100+3
equity 75.5% of total assets
Liquidity 97-2
short-term debt 14.4% · cash 46.8%
Profitability 89+89
return on assets 15.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,896 companies, NACE 46, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.2%▲ +0.1 percentage points vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025highest value 02-2026: < 0.1%▼ -0.2 percentage points vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €24,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.23 (5.45 in 2024), above the usual 1.5. Short-term debt is 14.4% and cash 46.8% of total assets. 24.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 90% of them on solvency, 94% on liquidity, 83% on profitability and 74% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-06-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 5.23, cash €155,213
NBB · annual accounts
lowers risk · Equity €250,609 (75.5% of total assets)
NBB · annual accounts
lowers risk · Founded in 2007
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Wholesale trade (NACE 46)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-01-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 days early
2024
25 days late
2023
26 days late
2022
28 days late
2021
23 days late
2020
24 days late
2019
10 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 16 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 25 February (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end05-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 29-01-2026 PDF all 18 filings

Turnover
≈ €270,000
Estimated: probably between €140,000 and €380,000
Total assets
€331,807▲ 12.1%
2024 · €296,016
Net result
€52,554
2024 · -€96,301
Working capital
€201,970▲ 23.6%
2024 · €163,472
Multi-year overview
2019 to 2025, 7 financial years
Operating result
€55,343
2025
20192025
Net result
€52,554
2025
highest quarter of the sector
20192025
Equity
€250,609
▲ 18.2% 2025
highest quarter of the sector
20192025
Total assets
€331,807
▲ 12.1% 2025
middle half of the sector
20192025
Debt
€81,198
▼ 3.3% 2025
20192025
Working capital
€201,970
▲ 23.6% 2025
highest quarter of the sector
20192025
Solvency
75.5%
▲ 3.9pp 2025
highest quarter of the sector
20192025
Current ratio
5.23
▼ 0.22 2025
highest quarter of the sector
20192025
Return on assets (ROA)
15.8%
▲ 48.4pp 2025
highest quarter of the sector
20192025
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result€61,189-€39,662▼ 35.2%€87,460▲ 121%€36,929▼ 57.8%€3,736▼ 89.9%-€93,056€55,343
Net result€41,160-€25,345above the sector's middle half▼ 38.4%€62,535above the sector's middle half▲ 147%€26,057within the sector's middle half▼ 58.3%€1,517within the sector's middle half▼ 94.2%-€96,301below the sector's middle half€52,554above the sector's middle half
Equity€192,901-€218,247above the sector's middle half▲ 13.1%€280,782above the sector's middle half▲ 28.7%€306,839above the sector's middle half▲ 9.3%€308,355above the sector's middle half▲ 0.5%€212,054above the sector's middle half▼ 31.2%€250,609above the sector's middle half▲ 18.2%
Total assets€270,770-€265,678within the sector's middle half▼ 1.9%€315,333within the sector's middle half▲ 18.7%€353,670within the sector's middle half▲ 12.2%€353,904within the sector's middle half▲ 0.1%€296,016within the sector's middle half▼ 16.4%€331,807within the sector's middle half▲ 12.1%
Debt€77,869-€47,431▼ 39.1%€34,552▼ 27.2%€46,831▲ 35.5%€45,549▼ 2.7%€83,962▲ 84.3%€81,198▼ 3.3%
Working capital€182,561-€212,475above the sector's middle half▲ 16.4%€276,489above the sector's middle half▲ 30.1%€303,701above the sector's middle half▲ 9.8%€303,907above the sector's middle half▲ 0.1%€163,472above the sector's middle half▼ 46.2%€201,970above the sector's middle half▲ 23.6%
Solvency71.2%-82.1%above the sector's middle half▲ 10.9pp89.0%above the sector's middle half▲ 6.9pp86.8%above the sector's middle half▼ 2.3pp87.1%above the sector's middle half▲ 0.4pp71.6%above the sector's middle half▼ 15.5pp75.5%above the sector's middle half▲ 3.9pp
Current ratio3.95-5.54above the sector's middle half▲ 1.599.08above the sector's middle half▲ 3.547.51above the sector's middle half▼ 1.577.70above the sector's middle half▲ 0.195.45above the sector's middle half▼ 2.245.23above the sector's middle half▼ 0.22
Return on assets (ROA)15.2%-9.5%within the sector's middle half▼ 5.7pp19.8%above the sector's middle half▲ 10.3pp7.4%within the sector's middle half▼ 12.5pp0.4%within the sector's middle half▼ 6.9pp-32.5%below the sector's middle half▼ 33.0pp15.8%above the sector's middle half▲ 48.4pp
above within below The sector band is the middle half of the companies in Wholesale trade (NACE 46). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is a profit of €55,343, after a loss of €93,056 in 2024. It is the highest result since 2021.

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €331,807
Fixed assets €82,085 ▼ 14.4%
Current assets €249,722 ▲ 24.8%
Equity and liabilities €331,807
Equity €250,609 ▲ 18.2%
Debt €81,198 ▼ 3.3%
Debt's share of the balance-sheet total falls from 28.4% to 24.5%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€69,640▲
2024 · -€81,215
Cash flow
€66,851▲
2024 · -€84,460
Debt to equity
0.32▼
2024 · 0.40
ROE
21.0%▲
2024 · -45.4%
Interest coverage
19.84▲
2024 · -23.12
Debt ≤ 1 year
€47,751▲
2024 · €36,699
Debt > 1 year
€33,447▼
2024 · €47,263
Income taxes
€2,498▲
2024 · €833
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Investments

fixed assets acquired
Item30-06-202230-06-202330-06-202430-06-2025
Tangible fixed assets€2,148€3,802€103,066€536
Depreciation and write-downs of the year€3,478€2,492€11,841€14,297

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet Code20242025
Assets
Total assets20/58€296,016€331,807▲
Fixed assets21/28€95,846€82,085▼
Tangible fixed assets22/27€95,846€82,085▼
Plant, machinery and equipment23€1,688€1,030▼
Furniture and vehicles24€94,158€81,055▼
Current assets29/58€200,170€249,722▲
Amounts receivable within one year40/41€7,373€43,432▲
Trade receivables40€6,482€42,807▲
Other amounts receivable41€891€625▼
Current investments50/53€48,781€48,781=
Cash at bank and in hand54/58€141,846€155,213▲
Deferred charges and accrued income490/1€2,171€2,296▲
Equity and liabilities
Total equity and liabilities10/49€296,016€331,807▲
Equity10/15€212,054€250,609▲
Contributions10/11€6,200€6,200=
Reserves13€302,155€244,409▼
Distributable reserves133€302,155€244,409▼
Profit (loss) carried forward14-€96,301-
Amounts payable17/49€83,962€81,198▼
Amounts payable after more than one year17€47,263€33,447▼
Financial debts170/4€47,263€33,447▼
Amounts payable within one year42/48€36,699€47,751▲
Current portion of amounts payable after more than one year42€13,210€13,816▲
Trade debts44€1,811€14,691▲
Suppliers440/4€1,811€14,691▲
Taxes, remuneration and social security45€6,435€2,078▼
Taxes450/3€3,706€2,078▼
Remuneration and social security454/9€2,729-
Other amounts payable47/48€15,242€17,167▲
Income statement Code20242025
Non-recurring operating income76A€31,222-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11,841€14,297▲
Other operating charges640/8€944€1,130▲
Gross operating margin9900-€80,271€70,770▲
Operating profit (loss)9901-€93,056€55,343▲
Financial income75/76B€1,102€3,220▲
Recurring financial income75€1,102€3,220▲
Financial charges65/66B€3,513€3,511▼
Recurring financial charges65€3,513€3,511▼
Profit (loss) for the period before taxes9903-€95,468€55,052▲
Income taxes67/77€833€2,498▲
Profit (loss) for the period9904-€96,301€52,554▲
Profit (loss) for the period to be appropriated9905-€96,301€52,554▲
Appropriation of the result
Profit (loss) to be appropriated9906-€96,301-€43,747▲
Profit (loss) brought forward from the previous period14P--€96,301
Transfer from equity791/2-€76,037
Transfer to equity691/2-€18,290
To other reserves6921-€18,290
Profit to be distributed694/7-€14,000
Return on contributions (dividend)694-€14,000

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 29-01-2026.

Line2019202020212022202320242025Change
Non-recurring operating income76A-----€31,222--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21,878€22,401€3,007€3,478€2,492€11,841€14,297▲ 20.7%
Other operating charges640/8---€868€944€944€1,130▲ 19.6%
Gross operating margin9900€83,902€62,915€91,322€41,275€7,173-€80,271€70,770-
Operating profit (loss)9901€61,189€39,662€87,460€36,929€3,736-€93,056€55,343-
Financial income75/76B---€1,348€1,077€1,102€3,220▲ 192%
Recurring financial income75€43€556€992€1,348€1,077€1,102€3,220▲ 192%
Financial charges65/66B---€776€767€3,513€3,511▼ 0.1%
Recurring financial charges65€1,753€2,647€990€776€767€3,513€3,511▼ 0.1%
Profit (loss) for the period before taxes9903€59,479€37,571€87,462€37,500€4,047-€95,468€55,052-
Income taxes67/77€18,318€12,226€24,926€11,443€2,530€833€2,498▲ 200%
Profit (loss) for the period9904€41,160€25,345€62,535€26,057€1,517-€96,301€52,554-
Profit (loss) for the period to be appropriated9905€41,160€25,345€62,535€26,057€1,517-€96,301€52,554-
Line2019202020212022202320242025Change
Assets
Total assets20/58€270,770€265,678€315,333€353,670€353,904€296,016€331,807▲ 12.1%
Fixed assets21/28€26,332€6,433€4,640€3,310€4,621€95,846€82,085▼ 14.4%
Tangible fixed assets22/27€26,332€6,433€4,640€3,310€4,621€95,846€82,085▼ 14.4%
Plant, machinery and equipment23---€1,532€3,425€1,688€1,030▼ 39.0%
Furniture and vehicles24---€1,779€1,196€94,158€81,055▼ 13.9%
Current assets29/58€244,439€259,245€310,693€350,360€349,283€200,170€249,722▲ 24.8%
Amounts receivable within one year40/41€39,006€45,053€27,615€32,273€17,841€7,373€43,432▲ 489%
Trade receivables40---€31,421€16,456€6,482€42,807▲ 560%
Other amounts receivable41---€852€1,385€891€625▼ 29.8%
Current investments50/53-€48,781€48,781€48,781€48,781€48,781€48,781=
Cash at bank and in hand54/58€205,432€165,411€234,297€265,692€278,889€141,846€155,213▲ 9.4%
Deferred charges and accrued income490/1---€3,614€3,773€2,171€2,296▲ 5.7%
Equity and liabilities
Total equity and liabilities10/49€270,770€265,678€315,333€353,670€353,904€296,016€331,807▲ 12.1%
Equity10/15€192,901€218,247€280,782€306,839€308,355€212,054€250,609▲ 18.2%
Contributions10/11€6,200--€6,200€6,200€6,200€6,200=
Reserves13€186,701€212,047€272,047€300,639€302,155€302,155€244,409▼ 19.1%
Non-distributable reserves130/1---€1,860€1,860---
Reserves not available under the articles1311---€1,860€1,860---
Distributable reserves133---€298,779€300,295€302,155€244,409▼ 19.1%
Profit (loss) carried forward14--€2,535---€96,301--
Amounts payable17/49€77,869€47,431€34,552€46,831€45,549€83,962€81,198▼ 3.3%
Amounts payable after more than one year17€15,992----€47,263€33,447▼ 29.2%
Financial debts170/4-----€47,263€33,447▼ 29.2%
Amounts payable within one year42/48€61,878€46,769€34,204€46,659€45,376€36,699€47,751▲ 30.1%
Current portion of amounts payable after more than one year42-----€13,210€13,816▲ 4.6%
Trade debts44€7,771€1,655€1,904€21,847€18,484€1,811€14,691▲ 711%
Suppliers440/4---€21,847€18,484€1,811€14,691▲ 711%
Taxes, remuneration and social security45---€18,056€17,017€6,435€2,078▼ 67.7%
Taxes450/3---€15,320€13,964€3,706€2,078▼ 43.9%
Remuneration and social security454/9---€2,736€3,053€2,729--
Other amounts payable47/48---€6,756€9,876€15,242€17,167▲ 12.6%
Accrued charges and deferred income492/3---€172€172---
Line2019202020212022202320242025Change
Profit (loss) for the period9904€41,160€25,345€62,535€26,057€1,517-€96,301€52,554-
+ Depreciation and write-downs630€21,878€22,401€3,007€3,478€2,492€11,841€14,297▲ 20.7%
Operating cash flow (approximation)€63,038€47,746€65,542€29,535€4,009-€84,460€66,851-
Investment in fixed assets (approximation)--€2,502-€1,214-€2,148-€3,802-€103,066-€536▲ 99.5%
Change in cash--€40,022€68,887€31,394€13,197-€137,043€13,367-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 34,693 companies had the same profile as COSMEDIC has now. Two years later, 95.3% were still going and 0.7% had gone bankrupt.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
95.3% was still going
3.9% stopped otherwise
0.7% went bankrupt

That fits the bankruptcy probability of COSMEDIC itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,693 companies, not a prediction for COSMEDIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Latest 10 of 18 filings with the National Bank
Financial year Type Filed Reference Document
30-06-2025 micro format 29-01-2026 2026-00024243 PDF
30-06-2024 micro format 25-02-2025 2025-00040571 PDF
30-06-2023 micro format 26-02-2024 2024-00034326 PDF
30-06-2022 micro format 28-02-2023 2023-00033950 PDF
30-06-2021 micro format 23-02-2022 2022-06200146 PDF
30-06-2020 micro format 24-02-2021 2021-06600192 PDF
30-06-2019 micro format 21-01-2020 2020-01700001 PDF
30-06-2018 micro format 07-12-2018 2018-73700196 PDF
30-06-2017 micro format 28-02-2018 2018-05500350 PDF
30-06-2016 abbreviated format 27-02-2017 2017-05100176 PDF

Show all 18 filings

Board & ownership

Directors

Directors
2 directors, last change in 2023
BARBAGELATA Christophe Dominique
Director (not named in the articles) · appointed in the act of 19-07-2023 · earlier manager, until 19-07-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 29-01-2026
Current
SMET Joyce Georges Hennie Judith Jane
Director (not named in the articles) · appointed in the act of 19-07-2023 · earlier manager, until 19-07-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 29-01-2026
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 19-07-2023

Owners and capital

Capital transactions

Capital over time
  1. 19-07-2023 Converted to unavailable equity · €8,060

Mandate history

2 people, 2 in office
Show
  • Board
  • mandate already running before its first mention
Mandates per person, with start and end dates
Name Functions and periods
BARBAGELATA Christophe Dominique
  • Manager, until 19-07-2023
  • Director (not named in the articles), appointed in the act of 19-07-2023, still in office
SMET Joyce Georges Hennie Judith Jane
  • Manager, until 19-07-2023
  • Director (not named in the articles), appointed in the act of 19-07-2023, still in office
See the board, name and registered office on a given date →

Articles of association

Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
186 shares

Articles of association, deed of 19-07-2023 (in Dutch)

Network & group

COSMEDIC shares no director with another company.

Connections & network

2 current directors
Depth

The network starts from the directors of COSMEDIC. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-01-2027
2026
29-01
NBB filing Annual accounts 2025 filedPDF
micro format · 2 days before the deadline
2025
30-06
Financial Back to profitnet €52,554
The net result is €52,554, after one loss-making year.
25-02
NBB filing Annual accounts 2024 filedPDF
micro format · 25 days late
2024
30-06
Financial Weakest financial yearnet -€96,301
The net result drops to -€96,301, the lowest from 2019 to 2025. It recovers the following year.
26-02
NBB filing Annual accounts 2023 filedPDF
micro format · 26 days late
2023
19-07
Gazette deed Changes of role: BARBAGELATA Christophe Dominique (director) and SMET Joyce Georges Hennie Judith Jane (director)
Director discharge: BARBAGELATA Christophe Dominique (manager) · Director discharge: SMET Joyce Georges Hennie Judith Jane (manager)8 points ▸
  • General meeting, 12-07-2023
  • Director resignation, BARBAGELATA Christophe Dominique (manager)
  • Director appointment, BARBAGELATA Christophe Dominique (director (not named in the articles))
  • Director resignation, SMET Joyce Georges Hennie Judith Jane (manager)
  • Director appointment, SMET Joyce Georges Hennie Judith Jane (director (not named in the articles))
  • Director discharge, BARBAGELATA Christophe Dominique (manager)
  • Director discharge, SMET Joyce Georges Hennie Judith Jane (manager)
  • Registered office clause, Ropstocklei 10, 2530 Boechout
  • The act holds 4 more points.

Open the act in the Belgian Official Gazette

28-02
NBB filing Annual accounts 2022 filedPDF
micro format · 28 days late
2022
23-02
NBB filing Annual accounts 2021 filedPDF
micro format · 23 days late
2021
30-06
Financial Highest result from 2019 to 2025net €62,535 ▲147%
The operating result of €87,460 and the net result of €62,535 are both a record.
24-02
NBB filing Annual accounts 2020 filedPDF
micro format · 24 days late
2020
30-06
Financial Equity above €200,000equity €218,247 ▲13.1%
With a profit in every financial year since 2019, equity grows to €218,247.
21-01
NBB filing Annual accounts 2019 filedPDF
micro format · 10 days before the deadline
Show earlier events
2018
07-12
NBB filing Annual accounts 2018 filedPDF
micro format · 55 days before the deadline
28-02
NBB filing Annual accounts 2017 filedPDF
micro format · 28 days late
2017
27-02
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 27 days late
2007
19-11
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

COSMEDIC was incorporated on 7 November 2007.1 Total assets rose from €270,770 in 2019 to €331,807 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Company details

Register details

Identity

KBO record
Name COSMEDIC in Dutch
Enterprise number 0893.282.995
Legal form Private limited company
Status Active, normale toestand
Founded 07-11-2007
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 19-07-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaamse Gewest”
deed of 19-07-2023 (in Dutch)

Registered office and establishments

Registered office Ropstocklei 10, 2530 Boechout, Belgium
Establishment unit COSMEDIC, Ropstocklei 10, 2530 Boechout since 31-10-2007 · unit number 2.166.562.306 4646001 Wholesale of pharmaceutical and medical goods
Phone 03/2809162 establishment in Boechout

Activities

NACEBEL 2025
46460 Wholesale of pharmaceutical and medical goods main activity
Codes under NACEBEL 2008
46460 Wholesale trade main activity
Codes under NACEBEL 2003
51460 main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“De uitwerking en de realisatie van projecten op het gebied van toestellen en materialen voor medische en paramedische toepassing; De…”
19 activities
  1. De uitwerking en de realisatie van projecten op het gebied van toestellen en materialen voor medische en paramedische toepassing;
  2. De groothandel in medisch-chirurgisch materieel en tandheelkundige instrumenten en benodigdheden;
  3. De groothandel in orthopedische artikelen;
  4. De kleinhandel in medische en orthopedische artikelen;
  5. Overige activiteiten in verband met gezondheidszorg,n.e.g.
  6. Vervaardiging van elektrische apparaten voor de geneeskunde,de tandheelkunde en de veeartsenijkunde;
  7. Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde,de tandheelkunde en de veeartsenijkunde;
  8. Vervaardiging van orthopedische artikelen en prothesen;
  9. Het verlenen van advies en praktische hulp aan de bedrijven in verband met public relations en communicatie;
  10. Het onderzoek naar de omvang van de markt voor bepaalde producten,de ontvangst en de bekendheid van producten en koopgewoonten,met het oog op de verkoopbevordering en de ontwikkeling van nieuwe producten;
  11. Overige adviesbureaus op het gebied van bedrijfsvoering en beheer;
  12. Het verlenen van adviezen en hulp aan het bedrijfsleven en de overheid op het gebied van planning,organisatie,efficiëntie en toezicht,het verschaffen van informatie aan de bedrijfsleiding,enzovoort;
  13. Het berekenen van de kosten en baten van de voorgestelde maatregelen op het gebied van planning,organisatie,efficiëntie,enzovoort;
  14. Handel in onroerend goed voor eigen rekening;
  15. De handel in eigen onroerend goed:flatgebouwen en woningen,niet voor bewoning bestemde gebouwen,grond.
  16. Verhuur van woningen,exclusief sociale woningen.
  17. Verhuur van sociale woningen.
  18. Verhuur van niet-residentiële gebouwen.
  19. Verhuur van terreinen.
deed of 19-07-2023 (in Dutch)

Invoicing and payment

VAT number BE 0893.282.995
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0893282995
Other Peppol ID 9925:BE0893282995
Registered 15-11-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 4 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 30-06
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of December at 18:00
deed of 19-07-2023 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map

Buildings and parcels at the address

Ground area
229 m²
Building footprint
94 m²
Building volume
601 m³
Cadastral parcel Region Area Buildings Height / floors
11004D0262/00R003 Flanders 229 m² 1 · 94 m² 11.0 m · 2